Stock ALGEN GENOWAY
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases genOway

Equities

ALGEN

FR0004053510

Real-time Euronext Paris
Other stock markets
 11:35:20 2024-05-23 am EDT 		5-day change 1st Jan Change
4.3 EUR -1.38% Intraday chart for genOway +1.18% -6.52%
2023 GenOway: sharp rise, broker initiates buy recommendation CF
2023 GENOWAY : Euroland initiates buy coverage CF

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
GenOway : Résultats annuels 2023
PU
GenOway : Résultats du 1er semestre 2023
PU
GenOway: Proposal of a new administrator
PU
GenOway grants the leading UK academic research funder a non-exclusive license for CRISPR/Cas9 technology
PR
GenOway : and Merck Strengthen CRISPR/Cas9 Strategic Alliance by Extending Their Partnership to All Animal Cell Models
AQ
GenOway : The Institut Pasteur and Cellectis extend exclusive license rights by granting genOway the authority to take action against infringement
PU
Genoway : Conventional KO (constitutive)
PU
GENOWAY : A grant for €1.9 million has been awarded under the Eurostars™ programme to a consortium that comprises Abzena, Antitope, Prothix BV, Aristi Biotech BV, the University Medical Center Utrecht, and genOway
PU
GENOWAY : The 11th ISTT Prize will be jointly awarded to Jennifer Doudna and Emmanuelle Charpentier at the TT2016 meeting.
PU
GENOWAY : Genetically Modified Models by CRISPR/Cas9 Nuclease System
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ALGEN Stock
  4. News genOway
  5. Press Releases